Xcell Biosciences Inc., An Instrumentation Company Focused On Cell And Gene Therapy Applications, And Acgt Vector, A Point-Of-Care Cell And Gene Therapy-As-A-Service (Taas) Company, Today Announced A Collaboration To Improve Manufacturing And Analytic Procedures Used To Develop Personalized Cell And Gene Therapies For Cancer Patients. Through This Alliance, Acgt Vector Will Provide Its Point-Of-Care, Gmp-Licensed Manufacturing Platform To Validate Xcellbio
